Oral Oncology
Volume 38, Issue 3 , Pages 251-257 , April 2002

Hypoxic induction of HIF-1α and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases

Received 28 February 2001 ,Accepted 9 April 2001.

References 

  1. Folkman J. The role of angiogenesis in tumor growth. Sem Cancer Biol. 1992;3:65–71
  2. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674
  3. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1990;82:4–6
  4. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N Eng J Med. 1991;324:1–8
  5. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994;79:185–188
  6. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25
  7. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms (deposition into the subepithelial extracellular matrix and bioactivity of ECM bound VEGF). Mol Biol Cell. 1993;4:1317–1326
  8. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Comm. 1992;189:824–831
  9. Phillips GD, Stone AM, Jones BD, Schultz JC, Whitehead RA, Knighton DR. Vascular endothelial growth factor (rhVEGF165) stimulates angiogenesis in the rabbit cornea. In Vivo. 1995;8:961–965
  10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364
  11. Shemirani B, Crowe DL. Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors. Oral Oncol. 1999;36:61–66
  12. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996;77:858–863
  13. Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, et al. Significance of vascular endothelial growth factor mRNA expression in primary lung cancer. Clin Cancer Res. 1996;2:1411–1416
  14. Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer. 1997;74:64–68
  15. Gleadle JM, Ratcliffe PJ. Induction of hypoxia inducible factor 1, erythropoietin, vascular endothelial growth factor, and glucose transporter 1 by hypoxia (evidence against a regulatory role for src kinase). Blood. 1997;89:503–509
  16. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1. Mol Cell Biol. 1996;16:4604–4613
  17. Tishcer E, Mitchell SR, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, et al. The human gene for vascular endothelial growth factor (multiple protein isoforms are encoded through alternative exon splicing). J Biol Chem. 1991;266:11947–11954
  18. Jiang BH, Agani F, Passaniti A, Semenza GL. V-src induces expression of hypoxia inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase I (involvement of HIF-1 in tumor progression). Cancer Res. 1997;57:5328–5335
  19. Zhong H, Agani F, Baccala AA, Laughner E, Rioseco-Camacho N, Isaacs WB, et al. Increased expression of hypoxia inducible factor 1α in rat and human prostate cancer. Cancer Res. 1998;58:5280–5284
  20. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995;270:14843–14846
  21. Davis RJ. The mitogen activated protein kinase signal tranduction pathway. J Biol Chem. 1993;268:14553–14556
  22. Seko Y, Takahashi N, Tobe K, Kadowaki T, Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen activated protein kinase (MAPK), and stress activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Comm. 1997;239:840–844
  23. Scott PH, Paul A, Belham CM, Peacock AJ, Wadsworth RM, Gould GW, et al. Hypoxic stimulation of the stress activated protein kinases in pulmonary artery fibroblasts. Am J Resp Crit Care Med. 1998;158:958–962
  24. Conrad PW, Rust RT, Han J, Millhorn DE, Beitner-Johnson D. Selective activation of p38α and p38γ by hypoxia. J Biol Chem. 1999;274:23570–23576
  25. Laderoute KR, Mendonca HL, Calaoagan JM, Knaoo AM, Giaccia AJ, Stork PJS. Mitogen activated protein kinase phosphatase (MKP1) expression is induced by low oxygen conditions found in solid tumor microenvironments. J Biol Chem. 1999;274:12890–12897
  26. Huang LE, Gu J, Schau M, Bunn HF. Regulation of the hypoxia inducible factor 1α is mediated by an O2 dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95:7987–7992
  27. Salceda S, Caro J. Hypoxia inducible factor 1α (HIF-1α) is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J Biol Chem. 1997;272:22642–22647
  28. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen activated protein kinases phosphorylate hypoxia inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1α. J Biol Chem. 1999;274:32631–32637

PII: S1368-8375(01)00052-5

Oral Oncology
Volume 38, Issue 3 , Pages 251-257 , April 2002

Article Tools

* Image Usage & Resolution